HealthMyne Names New CEO and Board Member with Deep Expertise and Experience in Healthcare Technology

MADISON, Wis.--()--HealthMyne, a Quantitative Imaging Decision Support company, has named Arvind Subramanian as its CEO and Board Member.

“Arvind provides outstanding leadership and executive management experience in both startup and large corporate environments to HealthMyne,” said Praveen Sinha, co-founder, board member and former CEO. “I am delighted to have him lead our company and look forward to working with him,” added Sinha, who remains a key member of the leadership team as Vice President of Business Development.

Arvind brings 30 years of general management, process and functional expertise to the executive suite: as his foundation, he spent over 10 years at the General Electric Company in the Jack Welch era where he held vice president/general manager positions for several business lines at GE Information Services and senior global product management, marketing, and strategic planning roles at GE Medical Systems.

After leaving GE in 1999, Arvind served on the executive management teams of two venture capital backed technology start-up companies, both of which completed successful exit strategies, including ProVation Medical, where he served as Chief Operating Officer prior to the company’s acquisition by Wolters Kluwer N.V. in January 2006.

Arvind was named President & CEO of Wolters Kluwer Health’s Clinical Solutions (CS) business unit in 2006, and subsequently led the business through double-digit acquisition and organic growth over a 10-year period to become the leading player in the global Point-of-Care market for clinical decision support medical content and clinical workflow driven application software.

“Arvind’s deep knowledge of healthcare technology markets and informatics, and his long and distinguished track record of value creation, execution, and leadership, make him the ideal candidate to lead HealthMyne on its mission to deliver a world-class Quantitative Imaging Decision Support (QIDS) software platform. His passion and commitment to building a strong culture and company is very motivating to customers, investors and employees,” said Scott Button, Managing Director, Venture Investors.

Arvind has 25 years of healthcare industry experience with a focus in the Diagnostic Imaging and Healthcare IT sectors. He received his BA and MBA degrees from Case Western Reserve University (Cleveland, Ohio). Arvind received an “Outstanding Entrepreneur” award from NEA (New Enterprise Associates, a top-tier global venture capital firm) for his role at ProVation Medical.

HealthMyne will be exhibiting (South Building, Hall A, Booth 4165) at the Annual Meeting of the Radiological Society of North America in Chicago from November 27 to December 2, 2016.

About HealthMyne:

HealthMyne, Inc. is focused on delivering Quantitative Imaging Decision Support (QIDS) for Radiology and Oncology with expansion to other clinical specialties and non-US markets over time. The company’s FDA-cleared software platform provides image quantification, analytics and medical content to improve clinical productivity; delivers precise patient management leveraging PACS, EMR, radiation therapy (RT) and other clinical systems data; and supports data mining for clinical and commercial research.

Contacts

HealthMyne Contact:
Jessica Frank
jessica.frank@healthmyne.com

Release Summary

HealthMyne, a Quantitative Imaging Decision Support company, has named Arvind Subramanian as its CEO and Board Member.

Contacts

HealthMyne Contact:
Jessica Frank
jessica.frank@healthmyne.com